T regulatory lymphocytes (Treg), defined by Cd4, Foxp3, and Il2ra gene expression31, were also increased in response to combination therapy, although collectively these represent < 1% of the total tumor-associated immune population (Fig. 5h). This evidence concerns the gene FOXP3 and neoplasm.